Despite advances in the diagnosis and management of psoriasis over the past 30 years,
disparities in the care for patients with psoriasis remain. Similar to other dermatologic …

Background The impact of childhood atopic dermatitis (AD) and psoriasis on school
absenteeism is not fully elucidated. Objective To determine the burden and predictors of …

Little is known about how psoriatic disease characteristics and treatment outcomes differ
geographically in the United States. Our aim was to explore real-world, geographic …

This study investigated whether systemic drug prescribing for psoriasis varies by season
and other exacerbating factors. Eligible patients with psoriasis were assessed for each …

Background: In March of 2017, dupilumab became the first FDA approved injectable biologic
for treatment of moderate-to-severe atopic dermatitis (AD). As the first drug in this class for …

Introduction Biologics have expanded the treatment options in the management of patients
with moderate-to-severe psoriasis. The objective of this study was to describe patient …

Background: How psoriasis disease characteristics, management, and outcomes each vary
across the US is not fully understood. Objective: Assess regional disease characteristics for …

We all have fought on grief's battleground; some of us started at early ages, while others
during their developmental age, teen's years, or later in their adulthood. All of them are …

Substantial regional differences in healthcare resource use and costs exist among patients
with psoriasis in the US, report researchers from that country. The researchers used cross …

Geographic Variations in Biologic Therapy and Disease Characteristics: A Pilot-Study in the
Corrona Psoriasis Registry. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …